You are here
- Home
Media
Here you will find our corporate press releases, details on upcoming events and other useful information for business and financial media.
-
Latest news expand
Financial results collapse
Third Quarter & Nine Months results 2009 announced Thursday, 29 October
2009. -
Key Facts collapse
- We are a world leading pharmaceutical company with a world-class biologics capability.
- We are active in over 100 countries with a growing presence in important emerging markets including China; corporate office in London, UK; and major R&D sites in Sweden, the UK and the US.
- We employ over 65,000 people (51% in Europe, 32% in the Americas and 17% in Asia, Africa and Australasia).
- Alongside our commitment to competitiveness and performance, we continue to be led by our core values to achieve sustainable success.
- More facts about AstraZeneca
Research & Development collapse
We focus our research on six disease areas where we believe our skills and experience can make the most difference.
Not signed in
Page tools
Share price
- London
-
26.95 GBP - New York
-
44.82 USD - Stockholm
-
310.10 SEK
At 21-Nov-2009 09:00 GMT
Detailed share priceIntroduction to AstraZeneca
Our responsibility
We continue to communicate openly on a range of issues, including:
